How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-04-01
著者
-
Izumi Namiki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Izumi Namiki
Division Of Gastroenterology And Hepatology Musashino Red-cross Hospital
関連論文
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- LAPAROSCOPLC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA
- Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival
- Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients
- Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis
- Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma : comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography
- Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
- Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome Associated with Primary Anti-Phospholipid Antibody Syndrome
- Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
- Changes of HCV quasispecies during combination therapy with interferon and ribavirin
- Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy
- A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression
- LAPAROSCOPIC ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA. CLINICAL SIGNIFICANCE OF A NEWLY DEVELOPED LAPAROSCOPIC SECTOR ULTRASONIC PROBE
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis
- Optimal timing of interferon treatment for acute hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers